Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
about
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewPredicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case RegistryImmunomodulatory drugs and their application to the management of canine immune-mediated disease.Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent.Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.Increased erythrocytic osmotic fragility in anemic domestic shorthair and purebred catsSystematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemiaDemographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia.The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use.Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research.Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs.Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.Effect of duration of packed red blood cell storage on morbidity and mortality in dogs after transfusion: 3,095 cases (2001-2010).Antiphospholipid antibodies in dogs with immune mediated hemolytic anemia, spontaneous thrombosis, and hyperadrenocorticism.In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.Seasonality of immune-mediated hemolytic anemia in dogs from southern California.Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia.Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.Effects of omega-3 polyunsaturated fatty acids and aspirin, alone and combined, on canine platelet function.Evaluation of prognostic indicators for canine primary immune-mediated haemolytic anaemia and application of a scoring system for the determination of prognosis.Bovine immune-mediated hemolytic anemia: 13 cases (November 2008-August 2009).Occurrence and potential causative factors of immune-mediated hemolytic anemia in cattle and river buffaloes.
P2860
Q26773178-8855F2B6-2606-452A-A9EC-150CFC2222F2Q28602895-899DE597-D503-4124-B1C0-48D2679C70BEQ33393823-888DD27F-56B5-431E-ACCA-AADC88289552Q33413713-7AA8BBFB-C7B8-4FD7-8298-93D85421C448Q33871622-8CF24CEB-2F06-45AE-B41D-4AC90F6D4842Q36327714-059AB87C-93E6-499B-AEC9-7BF6F8E1B45AQ36873665-AE1CEB1F-D8B4-4A4D-9184-3A837B5AE99FQ37020350-09ABDACC-A938-44CA-BA99-AA155C7DF640Q37277075-70D7AC6A-3C4A-45AB-8A98-17E907EBF545Q37731739-51821B13-B9E8-42EF-9EB7-1D9DD4F42E1CQ37949698-BD16AE29-9E09-4467-AA09-F06AFE7A3DDBQ38070814-BD43E5A8-C397-4E2A-89FC-A64F7FB1BD58Q38077297-5E766351-4A3E-48BD-9502-B0A33D180A27Q38259799-5EF16FD2-03CB-4FEE-9160-CE290630A095Q39630876-99371A6B-0C5A-40EF-AB90-60424B13DD66Q41073222-445BD429-B37C-40F6-B32A-875BAAF34007Q41075307-8DCF3E75-1B68-4686-9337-D16DB8B8DD42Q42218489-3D8E28F7-D255-46B1-B9A5-9E7BCC249D5FQ42593168-21E5BDF2-0BAA-42EC-9C96-A82341149439Q43923331-5FDE9A35-3A5F-4483-8C0F-B1029C83F867Q44062351-357FF7B0-8357-483F-B988-AEEB14039715Q46175382-2F1FF052-C6A2-4378-B81E-8BEFF239628CQ48162373-59ECF7D4-9103-4EC3-A8B4-085AAD7EB07FQ50098017-CAC2CEC3-E695-4969-9A65-22854CCB0B72Q50574707-4CA7C0F6-3E37-4663-8717-1E543F79A9E7Q50992904-E6019044-2BCA-493A-BC93-9E333F0FABDBQ54222891-51F2BDA7-2EBF-47D3-A418-447206B77775
P2860
Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@ast
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@en
type
label
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@ast
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@en
prefLabel
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@ast
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@en
P2093
P1476
Idiopathic immune-mediated hem ...... rognostic factors in 149 dogs.
@en
P2093
P304
P356
10.1111/J.1939-1676.2008.0060.X
P577
2008-03-10T00:00:00Z